Polycomb-dependent epigenetic landscape in adult T-cell leukemia.

Blood
Dai FujikawaToshiki Watanabe

Abstract

Adult T-cell leukemia-lymphoma (ATL) shows global gene expression alterations that confer cellular characteristics and unfavorable prognosis. However, molecular mechanisms of the sustained expression changes are largely unknown, because there is no study addressing the relationship between landscapes of the gene expression and epigenetic modifications. Here, we analyzed ATL epigenome and integrated it with transcriptome from primary ATL cells and those from corresponding normal CD4(+)T cells to decipher ATL-specific "epigenetic code" that was critical for cell identity. We found that polycomb-repressive complex 2 (PRC2)-mediated trimethylation at histone H3Lys27 (H3K27me3) was significantly and frequently reprogrammed at half of genes in ATL cells. A large proportion of the abnormal gene downregulation was detected at the early stage of disease progression and was explained by H3K27me3 accumulation. The global H3K27me3 alterations involved ATL-specific gene expression changes that included several tumor suppressors, transcription factors, epigenetic modifiers, miRNAs, and developmental genes, suggesting diverse outcomes by the PRC2-dependent hierarchical regulation. Interestingly, a key enzyme, EZH2, was sensitive to promiscuou...Continue Reading

References

Sep 18, 1997·Proceedings of the National Academy of Sciences of the United States of America·H MiyoshiI M Verma
Feb 12, 1998·Proceedings of the National Academy of Sciences of the United States of America·S TakemotoG Franchini
Sep 12, 1998·Journal of Virology·H MiyoshiI M Verma
Nov 15, 2002·International Journal of Hematology·Kazunari Yamaguchi, Toshiki Watanabe
Jun 4, 2005·Nucleic Acids Research·Shannan J Ho SuiWyeth W Wasserman
Mar 9, 2007·The Journal of Biological Chemistry·Takahiro TsujiWilliam W Hall
Oct 31, 2007·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Kunihiro TsukasakiUNKNOWN Japan Clinical Oncology Group Study JCOG9801
Aug 16, 2008·Retrovirology·Mathieu BoxusLuc Willems
Aug 30, 2008·Mutation Research·Jeffrey A Simon, Carol A Lange
Nov 26, 2008·Molecular Cell·Raphael MargueronDanny Reinberg
Dec 10, 2008·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Kunihiro TsukasakiToshiki Watanabe
Jan 10, 2009·Nature Protocols·Da Wei HuangRichard A Lempicki
Feb 5, 2010·Blood·Christian BachRobert K Slany
May 8, 2010·Blood·Masako IwanagaUNKNOWN Joint Study on Predisposing Factors of ATL Development investigators
Jun 30, 2010·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Ali BazarbachiOlivier Hermine
Aug 19, 2010·Blood·Daniel Martin-PerezMargarita Sanchez-Beato
Jan 21, 2011·Nature·Raphaël Margueron, Danny Reinberg
Feb 11, 2012·Proceedings of the National Academy of Sciences of the United States of America·Michael T McCabeCaretha L Creasy
Apr 5, 2012·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Hiroo KatsuyaKazuo Tamura
Apr 14, 2012·Nature Reviews. Drug Discovery·Cheryl H ArrowsmithMatthieu Schapira
Oct 13, 2012·Frontiers in Microbiology·Makoto Yamagishi, Toshiki Watanabe
Apr 2, 2013·Cell·Hui Shen, Peter W Laird
Jun 14, 2013·Nature Reviews. Cancer·Winston Timp, Andrew P Feinberg
Aug 15, 2013·Current Oncology Reports·Ambroise MarçaisAli Bazarbachi
Nov 16, 2013·Nature Reviews. Drug Discovery·Jonas W HøjfeldtKristian Helin
Feb 27, 2014·Nature Communications·Shingo NakahataKazuhiro Morishita

❮ Previous
Next ❯

Citations

May 31, 2016·Clinical Epigenetics·Koraljka Gall TrošeljDjurdjica Ugarkovic
Jun 9, 2017·Journal of Clinical and Experimental Hematopathology : JCEH·Hiroo Katsuya, Kenji Ishitsuka
Jun 20, 2017·Cancer Science·Yasunori Kogure, Keisuke Kataoka
Feb 13, 2018·Biology of the Cell·Makoto NakashimaRyouichi Horie
Dec 1, 2017·Journal of Clinical Medicine·Uyen Ngoc MuiStephen K Tyring
Nov 18, 2017·Annual Review of Immunology·Charles R M Bangham
Apr 9, 2016·Blood·Ali Bazarbachi
Jan 24, 2018·Proceedings of the National Academy of Sciences of the United States of America·Mohamed MahgoubMasao Matsuoka
Jul 10, 2019·Annual Review of Virology·Charles R M BanghamMasao Matsuoka
Oct 4, 2019·JCI Insight·Jingyu XiangKatherine N Weilbaecher
Jul 1, 2017·Current Opinion in Oncology·Makoto Yamagishi, Kaoru Uchimaru
Apr 7, 2020·Nature Reviews. Cancer·Danilo FioreGiorgio Inghirami
Jun 21, 2016·Oncotarget·Stefan NagelRoderick A F MacLeod
Aug 14, 2020·Blood·Christopher J Jolly, John E Pimanda
Jan 1, 2019·Uirusu·Kosuke ToyodaMasao Matsuoka
Mar 9, 2018·Frontiers in Microbiology·Stefania FochiMaria G Romanelli
Aug 9, 2018·Frontiers in Microbiology·Makoto YamagishiKaoru Uchimaru
Jun 18, 2020·Frontiers in Microbiology·Hiba El HajjOlivier Hermine
Jun 3, 2017·Current Hematologic Malignancy Reports·Jennifer K LueJennifer E Amengual
Apr 13, 2018·Frontiers in Microbiology·Sara MoodadHiba El Hajj
May 5, 2018·Molecules : a Journal of Synthetic Chemistry and Natural Product Chemistry·Regina Wan Ju WongTakaomi Sanda
Jul 11, 2020·Pathogens·Suchitra Mohanty, Edward W Harhaj
Jan 18, 2019·International Journal of Hematology·Yuetsu TanakaTakuya Fukushima
Aug 5, 2020·Experimental Dermatology·Francesca BelpinatiMacarena Gomez-Lira
Dec 15, 2020·British Journal of Haematology·Shingo Nakahata, Kazuhiro Morishita
Apr 14, 2019·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Jennifer K LueJennifer E Amengual
Oct 9, 2019·Molecular Cancer Research : MCR·Kazumi NakanoToshiki Watanabe
Sep 27, 2020·Cancer Research·Marie-Lisa EichSooryanarayana Varambally

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cell Signaling & Cancer Epigenetics (Keystone)

Epigenetic changes are present and dysregulated in many cancers, including DNA methylation, non-coding RNA segments and post-translational protein modifications. This feed covers the latest research on signaling and epigenetics in cell growth and cancer.